INVESTOR NEWS

May 15, 2018

First Quarter Financial Report

Moss, 15 May 2018

May 14, 2018

Share option program and compensation policy

On 14 May 2018, The Board of Directors of Gentian Diagnostics AS has decided to launch a share option program..

Apr 11, 2018

GENTIAN ACHIEVES PROOF OF CONCEPT ON WHOLE BLOOD HEMOGLOBIN WITH FERRITIN

GENTIAN DIAGNOSTICS AS HAS OBTAINED PROOF OF CONCEPT FOR A NEW PRODUCT FOR DIAGNOSING IRON DEFICIENCY AND..

Feb 27, 2018

4Q 2017 Results and preliminary annual report

Moss, 27 February 2018

Dec 12, 2017

Gentian Diagnostics appoints Njaal Kind as Group CFO

Moss, 4 December 2017

Dec 05, 2017

Flagging

Oslo, 4 December 2017

Dec 04, 2017

Gentian Diagnostics AS: Financial calendar

Financial calendar for Gentian Diagnostics AS

Nov 15, 2017

Third Quarter Financial Report

Moss, 15 November 2017

Nov 06, 2017

GENTIAN DIAGNOSTICS AS RECEIVES PATENT PROTECTION FOR THE COMPANY'S TECHNOLOGY FOR MONITORING TREATMENT OF HIV INFECTIONS

Moss, 06.11.2017

Oct 03, 2017

A new article published in CC&R is demonstrating the clinical value of plasma Calprotectin as an early biomarker of bacterial infections

Recently, the Critical Care and Resuscitation (CC&R) Journal published an article demonstrating the advantage..